Clinical Trial Update: Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating PSMA-PET and multiparametric MRI in high-risk prostate cancer with histopathologic validation; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Region Västerbotten | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING